Scientific Program CNS 2023
Chair: Tiffany Hodges, MD
Co-Chair: Kimberly Hoang, MD and Wajd Al-Holou, MD
Imagine, Innovate, Inspire are words familiar to our neurosurgical oncology community. Along these lines, we designed two scientific tumor sessions to continue our quest.
On Monday, September 11, the High-Grade Glioma Surgery: Challenges and New Frontiers will focus on the challenges of surgical resection of deep-seated high-grade gliomas, pre-surgical optimization, maintaining quality of life and functional balance in this patient population. This will be followed by “Novel Prospectives in Low Grade Glioma Management” where we will review and discuss updates in low-grade glioma management at initial diagnosis and at recurrence. Surgical, radiotherapy and systemic treatment considerations will be presented.
On Tuesday, September 12, the Innovation Driven by Neurosurgeons in Glioma Trials session will focus on opportunities/strategies for neurosurgeons to be involved in and lead early-stage glioma clinical trials. Phase III, micro-dialysis and CSF biomarker studies will be discussed in this session. This will be followed by
“New frontiers for Recurrent Neuro-Endocrine Tumors” where we will review and discuss the multidisciplinary management in recurrent neuroendrocrine tumors. Surgical, radiotherapy, medical and novel treatment paradigms will be discussed.
Don’t miss out on all other tumor related offerings including practical courses, luncheon seminars, guidelines sessions, and sunrise science! See you in Washington DC!
